Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
Sell
-418,400
Closed -$55M 30
2015
Q4
$55M Sell
418,400
-732,200
-64% -$98.4M 1.1% 22
2015
Q3
$159M Hold
1,150,600
3.53% 17
2015
Q2
$179M Buy
1,150,600
+95,709
+9% +$15.4M 3.62% 15
2015
Q1
$162M Hold
1,054,891
3.47% 18
2014
Q4
$162M Buy
1,054,891
+29,811
+3% +$4.74M 3.34% 17
2014
Q3
$186M Buy
1,025,080
+83,680
+9% +$15.2M 3.86% 12
2014
Q2
$163M Hold
941,400
3.93% 14
2014
Q1
$173M Hold
941,400
4.26% 10
2013
Q4
$169M Buy
941,400
+52,300
+6% +$9.02M 4.47% 11
2013
Q3
$157M Hold
889,100
5.18% 10
2013
Q2
$162M Buy
+889,100
New +$173M 5.75% 8

Other funds holding IBM

Wellcome Trust's IBM Position: Q1 2016 in Review

Wellcome Trust sold out of IBM (IBM) in Q1 2016, closing a stake of 418,400 shares — an estimated $55M sold.

Wellcome Trust first reported a position in IBM in Q2 2013 and held it in 11 quarters. The position peaked at $186M in Q3 2014. 1,714 funds tracked by Wall St. Rank hold IBM as of Q1 2016.

  • Wellcome Trust reported no remaining IBM position as of Q1 2016 after selling out during the quarter.
  • Wellcome Trust sold 418,400 IBM shares in Q1 2016, an estimated $55M.
  • Wellcome Trust first reported a position in IBM in Q2 2013 and held it in 11 quarters.
  • Wellcome Trust's IBM position peaked at $186M in Q3 2014.
  • 1,714 funds tracked by Wall St. Rank held IBM as of Q1 2016.

Based on Wellcome Trust's 13F filing for Q1 2016, filed 28 Apr 2016.